AlphaFold2 vs AlphaFold3 vs ESMFold: Which Protein Structure Prediction Tool Should You Use?

AlphaFold2 vs AlphaFold3 vs ESMFold: Which Protein Structure Prediction Tool Should You Use?

Three tools now dominate protein structure prediction. They’re not interchangeable — each makes different tradeoffs between accuracy, speed, scope, and accessibility. Here is how to choose the right one for your research.

The three tools at a glance

Gold standard
AlphaFold2
Best accuracy for single protein chains
Free
Complex predictor
AlphaFold3
Best for protein-ligand and protein-nucleic acid complexes
Free (limits)
Speed champion
ESMFold
Seconds per structure — built for scale
Free

If you’re not sure which to use and need a quick answer: check the AlphaFold Database first — your structure may already be there. If not, use AlphaFold2 via ColabFold for single proteins, AlphaFold3 for complexes, and ESMFold when you need to predict many structures quickly. Everything below explains when and why to deviate from that default.

AlphaFold2 — the single-chain benchmark

MSA + Evoformer
AlphaFold2
DeepMind / Google — released 2021 · model weights open source

AlphaFold2 remains the most accurate tool for predicting the structure of single protein chains. Released in 2021, it won CASP14 by such a large margin that many in the field declared single-chain structure prediction essentially solved for proteins with detectable evolutionary relatives. Its predictions for well-folded, globular proteins with good MSA coverage routinely achieve accuracy within 1–2 Å of experimental structures.

The most practical way to access AlphaFold2 predictions is the AlphaFold Protein Structure Database (alphafold.ebi.ac.uk), which hosts pre-computed models for over 200 million proteins — essentially every known protein. If your sequence is in UniProt, the model is probably already there. For sequences not in the database, ColabFold provides free AlphaFold2 predictions via Google Colab, with a simplified MSA pipeline that’s nearly as accurate as the full version and runs in 15–30 minutes per protein.

Strengths
  • Best accuracy for single protein chains
  • 200M+ pre-computed models in AFDB
  • Fully open source model weights
  • ColabFold: free, no installation
  • Per-residue pLDDT + PAE confidence output
  • Largest community and most tutorials
  • AlphaFold-Multimer extension for complexes
Limitations
  • Single deterministic output per run
  • Struggles with sparse MSAs (orphan proteins)
  • Predicts apo state — not ligand-bound conformation
  • Slower than ESMFold (minutes vs seconds)
  • Not designed for protein-small molecule complexes
  • Multimer accuracy drops for large complexes

AlphaFold3 — complexes and beyond

Diffusion architecture
AlphaFold3
Google DeepMind — released 2024 · web server access, restricted weights

AlphaFold3 represents the next generation of structure prediction — extending far beyond single proteins to predict structures of any molecular complex involving proteins, DNA, RNA, small molecule ligands, ions, and modified residues. This is the capability that makes it genuinely transformative: the ability to predict how a protein drug target interacts with a potential drug molecule, or how a transcription factor binds a specific DNA sequence, without needing an experimental structure.

Architecturally, AlphaFold3 replaces the Evoformer-based coordinate prediction with a diffusion model. Instead of predicting one deterministic structure, it generates multiple plausible structures by denoising from random atomic positions. This captures conformational diversity that AlphaFold2 misses — particularly relevant for flexible linkers, disordered regions, and binding interfaces that can adopt multiple states.

Access is via the AlphaFold Server (alphafoldserver.com), which imposes limits on the number of jobs per day for free accounts. The model weights are available under a license that restricts commercial use — a significant distinction from AlphaFold2’s fully open model.

Strengths
  • Predicts protein-ligand complexes natively
  • Handles protein-DNA and protein-RNA
  • Predicts protein-protein interfaces
  • Generates multiple conformations via diffusion
  • Handles modified residues and post-translational modifications
  • Best current option for covalent modification sites
Limitations
  • Commercial use restrictions on model weights
  • Web server has daily job limits
  • Not always better than AF2 for single proteins
  • Ligand pose accuracy variable — not a docking replacement
  • Confidence metrics (ipTM, pTM) less familiar than pLDDT
  • Smaller community and fewer tutorials than AF2
AF3 for drug discovery: important nuance
AlphaFold3’s protein-ligand predictions are impressive but not a replacement for molecular docking in virtual screening campaigns. AF3 predicts the binding mode of one ligand at a time and is not optimized for rapid screening of large compound libraries. Use AF3 to predict how a specific ligand of interest binds — not to screen thousands of compounds. For large-scale screening, use docking; for individual binding mode prediction, AF3 is excellent.

ESMFold — speed and scale

Language model
ESMFold
Meta AI — released 2022 · fully open source (MIT license)

ESMFold takes a fundamentally different approach: it skips the MSA entirely. Instead of searching sequence databases for evolutionary relatives, it uses a protein language model (ESM-2) trained on 250 million protein sequences to extract structural information directly from the sequence itself. The resulting representations are fed into a folding head that predicts 3D coordinates.

The practical payoff is extraordinary speed. AlphaFold2 takes 15–30 minutes per protein (including MSA generation). ESMFold takes seconds. This is not a marginal improvement — it’s a 100–1000× speedup that makes applications impossible with AlphaFold2 suddenly tractable: predicting structures for entire proteomes, running structure prediction in real-time pipelines, or rapidly screening thousands of engineered variants.

The accuracy tradeoff is real but context-dependent. For proteins with rich MSA coverage (most well-studied proteins), AlphaFold2 is significantly more accurate — it extracts more information from evolutionary data than ESMFold can extract from sequence alone. But for orphan proteins with sparse or no MSAs, the gap narrows considerably, and ESMFold’s speed advantage makes it competitive. The ESM Metagenomic Atlas provides pre-computed ESMFold structures for over 700 million metagenomic sequences — a scale impossible to achieve with AlphaFold2.

Strengths
  • Seconds per prediction — 100–1000× faster than AF2
  • No MSA required — one sequence in, structure out
  • MIT license — fully open, commercial use allowed
  • Best option for large-scale proteome-wide prediction
  • Competitive for orphan/low-homology proteins
  • Easy API access for pipeline integration
Limitations
  • Lower accuracy than AF2 for proteins with good MSAs
  • No native complex prediction capability
  • No per-residue confidence as detailed as pLDDT+PAE
  • Less accurate for multi-domain proteins
  • Not suitable when maximum accuracy is required

Full side-by-side comparison

Property AlphaFold2 AlphaFold3 ESMFold
Single protein accuracy Best in class Slightly lower than AF2 Good, less than AF2
Protein-protein complexes AF-Multimer (good) Best in class Not supported
Protein-ligand complexes Not supported Best in class Not supported
Protein-DNA / RNA Not supported Best in class Not supported
Prediction speed Minutes to hours Minutes Seconds
Orphan/low-homology proteins Struggles (MSA-dependent) Moderate Best available option
License Open source (Apache 2.0) Non-commercial only MIT — fully open
Free access Free (AFDB + ColabFold) Free server (daily limits) Free API
Confidence output pLDDT + PAE matrix pLDDT + ipTM + pTM pLDDT (no PAE)
Conformational diversity Single structure Multiple via diffusion Single structure
Best for large-scale screening Too slow for scale Moderate (server limits) Purpose-built for scale

Other tools worth knowing

The three tools above cover the majority of use cases, but several alternatives are worth knowing:

  • RoseTTAFold2 — open-source competitor to AlphaFold2 from David Baker’s lab at UW. Accuracy competitive with AF2, fully open for commercial use. RoseTTAFold2NA extends to nucleic acid complexes. Worth knowing if AF3’s license restrictions are a concern.
  • OpenFold — an open-source reimplementation of AlphaFold2 with a fully permissive license and retrained weights. Most useful for researchers who need to fine-tune or modify the model.
  • Boltz-1 / Chai-1 — emerging open-source alternatives to AlphaFold3 for complex prediction, with permissive licenses. The field is moving fast; these are worth watching as alternatives to AF3 if commercial use licensing is a concern.
  • Swiss-Model / MODELLER — traditional homology modeling tools still valuable for specific conformational states. Covered in the homology modeling tutorial on this site.
The field is moving fast
New models appear frequently. AlphaFold3 arrived three years after AF2 and changed the landscape significantly. Boltz-1 and Chai-1 arrived shortly after. When choosing a tool for a long-running project, check whether fully open alternatives to AF3 have matured — the licensing landscape for complex prediction is actively evolving.

Recommendations by user type

Default choice
Most researchers — single protein of interest
Check the AlphaFold Database first — your structure may already exist. If not, run ColabFold (AF2). Free, no installation, 15–30 minutes. Download the PDB and JSON confidence files. This covers 90% of use cases.
Complex work
Protein-ligand binding, protein-DNA, protein-protein interfaces
Use AlphaFold3 server (alphafoldserver.com). For protein-protein interactions, AF-Multimer via ColabFold is also excellent. For drug discovery applications where commercial use is needed, evaluate Boltz-1 or Chai-1 as open alternatives.
Scale
Predicting hundreds or thousands of structures
Use ESMFold via the API or locally. The speed advantage is decisive at scale — what takes days in ColabFold takes hours in ESMFold. If maximum accuracy is required for a subset, filter ESMFold predictions by pLDDT and re-run the high-value hits with ColabFold.
Orphan proteins
Poorly characterized proteins with few sequence homologs
Try both ESMFold and AlphaFold2 and compare confidence scores. For very sparse MSAs, ESMFold often performs competitively with AF2 and runs much faster. If pLDDT is low across both — the protein is probably genuinely disordered and no current tool will give a reliable structure.
Commercial use
Industry researchers, biotech, startups
AlphaFold2 (Apache 2.0 — commercial use allowed) and ESMFold (MIT) are both safe for commercial use. AlphaFold3 model weights are not licensed for commercial use — check the license before using AF3 predictions in any commercial context. RoseTTAFold2 is a strong open-source alternative for complex prediction.
Wet lab biologist
No computational background — just need a structure
Go to alphafold.ebi.ac.uk, search your protein by name or UniProt ID, download the PDB file. Done. If it’s not there, go to colab.research.google.com, search for “ColabFold”, paste your sequence, and run it. The entire process takes under 5 minutes of active work.

The verdict

Bottom line

For the vast majority of structural biology research — characterizing a single protein, understanding a disease mutation, preparing a structure for docking or MD simulation — AlphaFold2 via the AFDB or ColabFold is the right tool. It’s free, accurate, well-documented, and has the largest community.

Use AlphaFold3 when you need to understand how a protein interacts with a ligand, DNA, RNA, or another protein — it is the current best option for molecular complexes, with the caveat that its license restricts commercial use.

Use ESMFold when speed or scale matters more than maximum accuracy — large proteome studies, rapid screening of variants, or real-time pipeline integration. Its MIT license also makes it the cleanest choice for commercial applications.

The tools are complementary, not competitive. Many serious structural biology projects use all three at different stages.

Last updated on

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *